Send us a text

Ever wondered what’s actually inside a “homemade” dog diet—and whether it truly keeps dogs healthy? We sat down with researchers Drs. Janice O'Brien and Audrey Ruple from the Dog Aging Project to pull back the curtain on what owners are really feeding, what the data reveals, and how to make home-prepared meals complete and balanced without guesswork. The conversation starts with a major survey upgrade: moving from simple checkboxes to detailed free-text responses that capture real ingredients, supplements, and routines. That shift exposes a surprising truth—most DIY bowls contain nine to ten ingredients, far beyond chicken and rice, yet many still miss key nutrients for maintenance.

We walk through the practical and the personal: how to take a smarter diet history in the exam room, what owners should ask before they shop, and which tools can reliably build balanced recipes. Instead of fear or food wars, we focus on action. Consulting a board-certified veterinary nutritionist, using validated recipe platforms, and leveraging commercial base mixes can transform care and confidence. We also explore the long game. Do incomplete diets quietly shape future health risks? Which deficiencies matter most over time? Longitudinal data from the Dog Aging Project aims to turn those open questions into guidance that protects joints, skin, metabolism, and longevity.

There’s another layer that deserves attention: diversity among human owners. While our canine cohorts are broad, our human samples often aren’t. Culture, income, education, and access influence feeding choices, shopping habits, and follow-up care. Broadening who participates in pet nutrition research makes our recommendations more realistic and more fair. By the end, you’ll have a clearer view of where homemade feeding succeeds, where it stumbles, and how to build a plan that meets your dog’s needs today and supports health tomorrow.

If this conversation helped you think differently about dog nutrition, subscribe, share with a friend who home cooks, and leave a quick review—your feedback helps more pet owners find science they can use.

AJVR article: https://doi.org/10.2460/ajvr.25.06.0216

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® :

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

Send us a text

We sit down with Drs. Paul Freeman and Nick Jeffery to discuss a treatment for down dogs that’s changing outcomes and conversations: percutaneous intradiscal chondroitinase injections that act like chemical fenestration, reduce extruded disc material, and help non-ambulatory dogs recover without opening the spine.

We walk through the origin of the idea, the ethical hurdles, and the growing dataset behind safety and effectiveness. You’ll hear why deep pain–positive dogs with acute disc injuries often do as well with enzyme injections as with decompressive surgery, and how careful case selection can minimize risk. We get practical about inclusion criteria—currently focused on dogs under 15 kg, with French Bulldogs now included under close monitoring—and the technical realities of needle placement, imaging guidance, and when to add MRI. We also dig into the strategy of treating three to five disc levels to lower recurrence, and why this multi-level approach could outperform single-site surgery over the long term.

The conversation doesn’t dodge the hard calls. We compare large compressive lesions versus primarily contusive injuries, discuss when early surgery still makes sense, and share early experiences expanding to cervical cases with ultrasound and fluoroscopic checks. Looking ahead, we explore research priorities: defining time windows for chronic presentations, tracking recurrence across breeds, and building the evidence to place chondroitinase correctly in the treatment pathway. We even touch on how AI could one day use imaging data to predict which dogs need urgent decompression and which can safely recover with enzyme-first care.

If you’re an ER vet, GP, or neurologist looking to offer owners real choices, this is a grounded, data-informed guide to a less invasive option that can preserve mobility and reduce euthanasia driven by cost. Listen, share with your team, and help more “down dogs” stand again. Subscribe, leave a review, and tell us: where would you place chondroitinase in your spinal care protocol?

JAVMA article: https://doi.org/10.2460/javma.24.12.0790

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® :

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

Send us a text

Ever notice how the smallest habits in surgery are the hardest to justify with data? We dig into one of those everyday choices—taper vs. reverse cutting needles for intradermal closure after TPLO—and unpack what the evidence actually says about early incisional healing, complication rates, and the subtle differences that might matter at the 18–24 hour mark. With surgeon-researcher Josh Becker, we trace the path from hunches and mentor preferences to a pragmatic study design that could live in private practice and still push the conversation forward.

We talk candidly about why “non-inferiority” can be a messy label without a clear gold standard, how blinding and standardized photos helped keep bias in check, and why the simplest takeaway is also the most practical: both needle types can perform well in healthy TPLO patients. Josh shares when he reaches for taper vs. cutting based on tissue characteristics and body region, and we explore the mindset shift from “what I’ve always used” to “what this patient and this tissue need today.” The conversation also opens a bigger door: if veterinary medicine had a validated, objective incision scoring system, we could compare techniques, icing and heat protocols, bandaging, and mobilization with far more confidence.

Looking ahead, we map out next steps—replicating signals, expanding to other anatomical sites, and experimenting with image-based analytics or AI to quantify erythema and bruising consistently. Along the way, we keep it human: debriefs after cases, the humility of soft tissue surgery, and advice for students who want to build a thoughtful, evidence-aware surgical career. If you’ve ever argued for a needle out of habit, this episode invites you to choose with intention and ask for proof.

If this conversation helped refine your setup or sparked a change in your closure routine, subscribe, share the episode with a colleague, and leave a review—your feedback helps more vets find data they can use tomorrow.

JAVMA article: https://doi.org/10.2460/javma.25.07.0479

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® :

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals